Back to Search
MAJD MICHAEL, M.D.
M.D.
Gastroenterology Physician
NPI: 1306223177IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
A151364(CA)
CMS Specialties
PrimaryGASTROENTEROLOGY
Education
OTHER
Class of 2012
Research & Publications (20)
Responses on a lateralized lexical decision task relate to both reading times and comprehension.
PMID 19559514·Brain Cogn·2009
8-other
Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer.
PMID 19002384·Invest New Drugs·2009
3-trial
A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer.
PMID 19088724·Br J Cancer·2009
3-trial
Drug metabolism by tumours: its nature, relevance and therapeutic implications.
PMID 18028025·Expert Opin Drug Metab Toxicol·2007
6-review
Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug elimination.
PMID 16896007·J Clin Oncol·2006
8-other
Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil count.
PMID 17241514·Clin Colorectal Cancer·2006
8-other
Tumoral drug metabolism: overview and its implications for cancer therapy.
PMID 15625375·J Clin Oncol·2005
6-review
A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC.
PMID 16222311·Br J Cancer·2005
3-trial
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
PMID 15514383·J Clin Oncol·2004
3-trial
Effects of insulin-sensitising agents in mice with hepatic insulin resistance.
PMID 14730378·Diabetologia·2004
7-preclinical
Reduced accumulation of specific microRNAs in colorectal neoplasia.
PMID 14573789·Mol Cancer Res·2003
8-other
Inhibition of cyclooxygenase-2 and activation of peroxisome proliferator-activated receptor-gamma synergistically induces apoptosis and inhibits growth of human breast cancer cells.
PMID 12736714·Int J Mol Med·2003
8-other
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian Trial.
PMID 12453323·Clin Colorectal Cancer·2002
3-trial
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.
PMID 10949030·Mol Cell·2000
7-preclinical
Panayiotopoulos syndrome: an important childhood autonomic epilepsy to be differentiated from occipital epilepsy and acute non-epileptic disorders.
PMID 19386455·Brain Dev·2010
6-review
Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity.
PMID 19470704·Endocrinology·2009
7-preclinical
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation.
PMID 19492298·Stem Cells·2009
8-other
Use of stabilizing mutations to engineer a charged group within a ligand-binding hydrophobic cavity in T4 lysozyme.
PMID 19663503·Biochemistry·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3501 PALMER DR STE 201
CAMERON PARK, CA 95682 - Phone
- (832) 712-7053
Quick Facts
- NPI
- 1306223177
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile